Document ID: chunk:federal_register_of_legislation:F2024L01524:schedule:1:p9
Version: federal_register_of_legislation:F2024L01524
Segment Type: schedule
Provision Reference: sch 1 (pt 9/38)
Character Range: 23481–26416

Nirmatrelvir and ritonavir
omit from the column headed "Circumstances": C13748 C13759 C13821 C15049 substitute: C16155 C16156 C16192 C16223
[64] Schedule 1, Part 1, entries for Nivolumab with relatlimab
substitute:
Nivolumab with relatlimab  Solution concentrate for I.V. infusion containing 240 mg nivolumab and 80 mg relatlimab in 20 mL  Injection  Opdualag  BQ  MP  C16151 C16188     See Note 3  See Note 3     1     D(100)

[65] Schedule 1, Part 1, after entry for Olmesartan with amlodipine in the form Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) [Brand: Sevikar 20/5; Maximum Quantity: 60; Number of Repeats: 5]
insert:
Olmesartan with amlodipine  Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate)  Oral  APO-OLMESARTAN/AMLODIPINE 40/10  TY  MP NP  C4373   P4373   30  5     30
Olmesartan with amlodipine  Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate)  Oral  APO-OLMESARTAN/AMLODIPINE 40/10  TY  MP NP  C14839  P14839  60  5     30

[66] Schedule 1, Part 1, entries for Paraffin in the form Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g
omit:
Paraffin  Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g  Application to the eye  Refresh Night Time  VE  MP NP AO             1  5     1
Paraffin  Pack containing 2 tubes eye ointment, compound, containing white soft paraffin with liquid paraffin, 3.5 g  Application to the eye  Refresh Night Time  VE  MP NP AO     P14238  2  5     1

[67] Schedule 1, Part 1, after entry for Pioglitazone in the form Tablet 45 mg (as hydrochloride) [Brand: APOTEX-Pioglitazone; Maximum Quantity: 56; Number of Repeats: 5]
insert:
Pioglitazone  Tablet 45 mg (as hydrochloride)  Oral  ARX-PIOGLITAZONE  XT  MP NP  C15321  P15321  28  5     28
Pioglitazone  Tablet 45 mg (as hydrochloride)  Oral  ARX-PIOGLITAZONE  XT  MP NP  C15290  P15290  56  5     28

[68] Schedule 1, Part 1, omit entry for Prochlorperazine in the form Tablet containing prochlorperazine maleate 5 mg (S19A)
[69] Schedule 1, Part 1, after entry for Rivaroxaban in the form Tablet 2.5 mg [Brand: Rivaroxaban-Teva; Maximum Quantity: 120; Number of Repeats: 5]
insert:
Rivaroxaban  Tablet 2.5 mg  Oral  RIVOXA  CR  MP NP  C10992  P10992  60   5     60
Rivaroxaban  Tablet 2.5 mg  Oral  RIVOXA  CR  MP     C11013  P11013  60   5     60
Rivaroxaban  Tablet 2.5 mg  Oral  RIVOXA  CR  MP NP  C14298  P14298  120  5     60

[70] Schedule 1, Part 1, after entry for Rivaroxaban in the form Tablet 10 mg [Brand: iXarola; Maximum Quantity: 60; Number of Repeats: 5]
insert:
Rivaroxaban  Tablet 10 mg  Oral  Rivaroxaban Sandoz  SZ  MP NP  C4402   P4402   30  0     30
Rivaroxaban  Tablet 10 mg  Oral  Rivaroxaban Sandoz  SZ  MP NP  C4132   P4132   30  5     30
Rivaroxaban  Tablet 10 mg  Oral  Rivaroxaban Sandoz  SZ  MP